Podcasts Government The Dose What’s Missing From the Debate About Controlling Drug Costs?

What’s Missing From the Debate About Controlling Drug Costs?

Published: Jan. 31, 2020, 10 a.m.

Prescription medicines have become so expensive in the United States that we've reached a point where four in five Americans think drug prices are unreasonable. While political leaders have certainly taken notice, what are they doing to solve the problem?

On the latest episode of The Dose, host Shanoor Seervai sits down with the Commonwealth Fund’s Lovisa Gustafsson to talk about how drugs could be made more affordable for those who bear the brunt of high prices – ordinary Americans.

Gustafsson believes some important issues are missing from the drug pricing debate, including a broken patent system, high launch prices, and the lack of cheaper medical treatments.